Mineralys Therapeutics
MLYS
MLYS
149 hedge funds and large institutions have $971M invested in Mineralys Therapeutics in 2025 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 53 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
38% more funds holding
Funds holding: 108 → 149 (+41)
4.02% more ownership
Funds ownership: 93.4% → 97.42% (+4%)
39% less call options, than puts
Call options by funds: $6.05M | Put options by funds: $9.94M
Holders
149
Holding in Top 10
10
Calls
$6.05M
Puts
$9.94M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$22.6M | |
| 3 | +$20.6M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
+$19.3M |
| 5 |
CP
Caligan Partners
New York
|
+$18.1M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$13.9M | |
| 3 | -$10.8M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$9.18M |
| 5 |
JPMorgan Chase & Co
New York
|
-$7.67M |
